Puma Biotech (PBYI) on Watch as Offering Said in Doubt

October 19, 2016 1:25 PM EDT

Get access to the best calls on Wall Street with StreetInsider.com's Ratings Insider Elite. Get your Free Trial here.

Puma Biotech (NYSE: PBYI) was in focus amid doubts about the success of its $150 million common stock offering.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In






Related Categories

Rumors, Trader Talk

Related Entities

Equity Offerings, Adam Feuerstein

Add Your Comment